Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study CK A Djarmati, SA Schneider, K Lohmann, S Winkler, H Pawlack, J Hagenah N ... The Lancet Neurology 8 (5), 447-52, 2009 | 285* | 2009 |
Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene K Lohmann, RA Wilcox, S Winkler, A Ramirez, A Rakovic, JS Park, B Arns, ... Annals of neurology 73 (4), 537-545, 2013 | 175 | 2013 |
New developments in the molecular pharmacology of the myo-inositol 1, 4, 5-trisphosphate receptor RA Wilcox, WU Primrose, SR Nahorski, RAJ Challiss Trends in pharmacological sciences 19 (11), 467-475, 1998 | 122 | 1998 |
Persistent abnormality detected in the non-ictal electroencephalogram in primary generalised epilepsy JO Willoughby, SP Fitzgibbon, KJ Pope, L Mackenzie, AV Medvedev, ... Journal of Neurology, Neurosurgery & Psychiatry 74 (1), 51-55, 2003 | 114 | 2003 |
The symbol of modern medicine: why one snake is more than two RA Wilcox, EM Whitham Annals of internal medicine 138 (8), 673-677, 2003 | 93 | 2003 |
Synthesis of 1D-3-deoxy-, 1D-2, 3-dideoxy-, and 1D-2, 3, 6-trideoxy-myo-inositol 1, 4, 5-trisphosphate from quebrachitol, their binding affinities, and calcium release activity AP Kozikowski, VI Ognyanov, AH Fauq, SR Nahorski, RA Wilcox Journal of the American Chemical Society 115 (11), 4429-4434, 1993 | 87 | 1993 |
Pedunculopontine nucleus deep brain stimulation produces sustained improvement in primary progressive freezing of gait RA Wilcox, MH Cole, D Wong, T Coyne, P Silburn, G Kerr Journal of Neurology, Neurosurgery & Psychiatry 82 (11), 1256-1259, 2011 | 82 | 2011 |
Whispering dysphonia in an Australian family (DYT4): a clinical and genetic reappraisal RA Wilcox, S Winkler, K Lohmann, C Klein Movement disorders 26 (13), 2404-2408, 2011 | 77 | 2011 |
2-Hydroxyethyl α-D-glucopyranoside 2,3′,4′-trisphosphate: a novel metabolically resistant adenophostin A and myo-inositol 1,4,5-trisphosphate analogue potently interacts … RA Wilcox, C Erneux, WU Primrose, R Gigg, SR Nahorski Biochemical Society Transactions 23 (3), 420S-420S, 1995 | 70 | 1995 |
3-position modification of myo-inositol 1, 4, 5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition ST Safrany, RA Wilcox, C Liu, BVL Potter, SR Nahorski European Journal of Pharmacology: Molecular Pharmacology 226 (3), 265-272, 1992 | 65 | 1992 |
Hashimoto’s encephalopathy masquerading as acute psychosis RA Wilcox, T To, A Koukourou, J Frasca Journal of Clinical Neuroscience 15 (11), 1301-1304, 2008 | 61 | 2008 |
Modification at C2 of myo‐inositol 1,4,5‐trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities RA Wilcox, ST Safrany, D Lampe, SJ Mills, SR Nahorski, BVL Potter European journal of biochemistry 223 (1), 115-124, 1994 | 58 | 1994 |
The personal digital assistant: a new medical instrument for the exchange of clinical information at the point of care RA Wilcox, RR La Telia Medical journal of Australia 175 (11-12), 659-662, 2001 | 52 | 2001 |
Identification of partial agonists with low intrinsic activity at the inositol-1, 4, 5-trisphosphate receptor. ST Safrany, RA Wilcox, C Liu, D Dubreuil, BV Potter, SR Nahorski Molecular pharmacology 43 (4), 499-503, 1993 | 48 | 1993 |
Evidence for the involvement of a small subregion of the endoplasmic reticulum in the inositol trisphosphate receptor-induced activation of Ca2+ inflow in rat hepatocytes RB Gregory, RA Wilcox, LA Berven, NCRVAN STRATEN, ... Biochemical Journal 341 (2), 401-408, 1999 | 47 | 1999 |
Inositol-1, 3, 4, 5-tetrakisphosphate induces calcium mobilization via the inositol-1, 4, 5-trisphosphate receptor in SH-SY5Y neuroblastoma cells. RA Wilcox, RA Challiss, C Liu, BV Potter, SR Nahorski Molecular pharmacology 44 (4), 810-817, 1993 | 45 | 1993 |
Molecular recognition at the myo-inositol 1, 4, 5-trisphosphate receptor. 3-position substituted myo-inositol 1, 4, 5-trisphosphate analogues reveal the binding and Ca2+ … RA Wilcox, RA Challiss, JR Traynor, AH Fauq, VI Ognayanov, ... Journal of Biological Chemistry 269 (43), 26815-26821, 1994 | 42 | 1994 |
Adults with a history of illicit amphetamine use exhibit abnormal substantia nigra morphology and parkinsonism G Todd, V Pearson-Dennett, RA Wilcox, MT Chau, K Thoirs, D Thewlis, ... Parkinsonism & Related Disorders 25, 27-32, 2016 | 41 | 2016 |
Stable overexpression of the type-1 inositol 1, 4, 5-trisphosphate receptor in L fibroblasts: subcellular distribution and functional consequences JJ MACKRILL, RA Wilcox, A MIYAWAKI, K MIKOSHIBA, SR NAHORSKI, ... Biochemical Journal 318 (3), 871-878, 1996 | 41 | 1996 |
Stereoselectivity of Ins(1,3,4,5)P4 recognition sites: implications for the mechanism of the Ins(1,3,4,5)P4-induced Ca2+ mobilization RA Wilcox, RA Challiss, G Baudin, A Vasella, BV Potter, SR Nahorski Biochemical Journal 294 (1), 191-194, 1993 | 41 | 1993 |